Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management

Bisphosphonates (BPs) are widely used in the treatment of postmenopausal osteoporosis and other metabolic bone diseases. They bind strongly to bone matrix and reduce bone loss through inhibition of osteoclast activity. They are classified as nitrogen- and non-nitrogen-containing bisphosphonates (NBP...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalle Carbonare, Luca, Zanatta, Mirko, Gasparetto, Adriano, Valenti, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108695/
https://www.ncbi.nlm.nih.gov/pubmed/21701624
http://dx.doi.org/10.2147/DHPS.S6285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108695/
https://www.ncbi.nlm.nih.gov/pubmed/21701624
http://dx.doi.org/10.2147/DHPS.S6285

Ejemplares similares